Evicenter
Keytruda (pembrolizumab) in High-risk early-stage triple-negative breast cancer
Manufacturer
Merck Sharp & Dohme LLC
Prescribing information
Keytruda (opens in a new tab)
Questions
28
Last updated

All questions

Access and coverage: Keytruda (pembrolizumab) in high-risk early-stage triple-negative breast cancer

3 questions · 3 sources

Access and billing

What are the NDC codes for KEYTRUDA?

Access and support

Is there a KEYTRUDA patient support program?

Who can answer KEYTRUDA reimbursement and copay assistance questions?

Note: The page links to the Merck Access Program site (merckaccessprogram-keytruda.com), a separate host outside the capture scope; program terms and eligibility are not quoted.